Outsourcing

Oct 01, 2017
BioPharm International
Mergers and acquisitions are positive for the CDMO industry, but there is a downside.
Sep 26, 2017
By BioPharm International Editors
ADC Bio announces plans to expand into clinical and commercial drug manufacturing for ADCs.
Sep 21, 2017
By BioPharm International Editors
Ajinomoto Althea opens manufacturing suites in new high potency and antibody drug conjugate commercial facility.
Sep 19, 2017
By BioPharm International Editors
The acquisition adds to Catalent’s capabilities in biologics development, analytical services, manufacturing, and finished product supply.
Sep 01, 2017
BioPharm International
Innovation speeds discovery, drives down costs, and improves productivity.
Aug 01, 2017
BioPharm International
Despite some progress, the industry is still in a wait-and-see mode regarding the administration, Congress, and FDA.
Jul 21, 2017
By BioPharm International Editors
Contract manufacturers await a promising pipeline of drug products to jump-start stagnant growth.
Jul 18, 2017
By BioPharm International Editors
The addition of 20,000 sq. ft. of manufacturing and office space increases Avecia’s Milford, Ma, oligonucleotide capacity to 3.0 mol.
Jul 18, 2017
By BioPharm International Editors
Catalent expands the scope of the OptiForm Solution Suite to bridge gap from late-stage discovery to Phase I trials.
Jul 18, 2017
By BioPharm International Editors
Alcami will move its headquarters to Durham, NC while maintaining its manufacturing and laboratory operations in Wilmington, NC.
native1_300x100
lorem ipsum